Neurometabolomics Research Center (NRC)
Pioneering the field of neurometabolomics, the first of its kind in Asia, garnering attention in the 21st-century medical industry.
Neurometabolomics Research Center (NRC)
To lead the preemption of the burgeoning field of metabolomics, regarded as the largest medical industry of the 21st century, DGIST spearheaded the establishment of the nation's first and largest Neurometabolomics Research Center (NRC) within its campus.
Research Goals
- Leveraging DGIST's world-leading expertise in neurometabolomics, state-of-the-art analytical equipment and technology from Agilent Technologies, accumulated research capabilities from the Johns Hopkins University's Obesity Metabolism Research Center, and the strengths of medical infrastructure in Daegu, including university hospitals and pioneering ventures, the center aims to grow into a global leader in medical research within a short period. Through international collaborative research in neurometabolomics among the United States, Singapore, Australia, and Korea, the center seeks to foster human resources responsible for neurometabolomics research domestically and internationally. Additionally, the center aims to provide integrated technologies for early disease diagnosis.
Major Research Fields & Contents
- The center aims to elucidate key neurometabolites involved in brain function regulation and explore the potential of controlling neuronal cell function based on neurometabolite regulation, utilizing recently emerging metabolomic analysis technologies. It seeks to discover new neurometabolites by leveraging these technologies, which may shed light on the regulation of brain metabolism and neuronal function control.
- Through research on the pathogenesis of various disorders related to neuronal cell metabolism abnormalities (including dementia, stroke, depression, suicidal impulses, aggressive personality disorders, as well as metabolic disorders such as obesity, diabetes, hypertension, myocardial infarction), the center aims to predict the onset time and pattern of individual diseases.
- By using metabolomic analysis, the center intends to develop methods for identifying specific metabolites related to certain diseases, facilitating disease classification and evaluation of responses to treatments. These methods can then be utilized as targets for treatment strategies through monitoring and classification of high-risk groups.
Director
Eun-Kyoung Kim
Tel
053-785-6111
E-mail
ekkim@dgist.ac.kr